UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2021 OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 _________________________________________ TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) ____________ ...

Tenet Healthcare Corporation (NYSE:THC) Q1 2021 Earnings Conference Call April 21, 2021 10:00 AM ET Company Representatives Ron Rittenmeyer - Executive Chairman and Chief Executive Officer Saum Sutaria - President and Chief Operating Officer Dan Cancelmi - Executive Vice President and Chief Financial Officer Brett Brodnax - CEO and President of USPI Regina Nethery - Vice President of Investor Relations Conference Call Participants Josh Raskin - Nephron Research John Ransom - Raymond James Brian Tanquilut - ...

First Quarter 2021 Earnings Release Presentation April 20, 2021 Cautionary Statements This presentation includes "forward-looking statements." These statements relate to future events, including, but not limited to, statements regarding our liquidity, operating results, future earnings, financial position, operational and strategic initiatives, and developments in legislation, regulation, and the healthcare industry more generally. These forward-looking statements represent management's expectations, based ...

Financial Performance & Outlook - FY 2020 Consolidated Adjusted EBITDA excluding grant income was $2247 million[8] - FY 2020 Consolidated Adjusted EBITDA including grant income was $3146 million[8] - Q4 2020 Consolidated Adjusted EBITDA was $1278 million including grant income[19] - The company expects to finish 2021 below 5x leverage ratio[11] - The company anticipates $140 million in proceeds from divesting urgent care business and completing MOB sale[29] - The company expects annualized interest savings of ~$33 million from retiring $478 million of 7% senior unsecured notes due in 2025[11, 29] - The company projects FY 2021 Adjusted EBITDA to be $3000 million[35] Operational Highlights - Conifer Adjusted EBITDA increased 18.1% to $111 million in Q4 2020[7] - Conifer's revenues increased by 3.6% and revenues from 3rd party clients increased 5.2% from Q4 2019[7] - The company acquired 45 ambulatory surgery centers from SurgCenter Development in December 2020[11] - USPI's surgical cases were 95% of Q4-2019 volumes[18]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2020 OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 ________________________________________ TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) ...

Tenet Healthcare Corporation (NYSE:THC) Q4 2020 Earnings Conference Call February 10, 2021 10:00 AM ET Company Participants Regina Nethery - Vice President, Investor Relations Ron Rittenmeyer - Executive Chairman & Chief Executive Officer Dan Cancelmi - Executive Vice President & Chief Financial Officer Saum Sutaria - President and Chief Operating Officer Conference Call Participants Kevin Fischbeck - Bank of America Pito Chickering - Deutsche Bank Justin Lake - Wolfe Research Jamie Perse - Goldman Sachs F ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2020 OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 _________________________________________ TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) ________ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2020 OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 _________________________________________ TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) _____________ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 (State of Incorporation) (IRS Employer Identification No.) 14201 Dallas Parkway Dallas, TX 75254 (Address of principal executive offices, including zip code) Form 10-Q ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2020 OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission ...

Form 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2019 OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 ________________________________________ TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ...